Atrial fibrillation in preterm neonates: A case study

Li, Hua-lian; Wei, Xin; Zheng, Fei; Wen, Jie; Sun, Guoqiang

doi:10.1016/j.jelectrocard.2021.01.009

Cited by 4 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the absence of structural heart disease and hemodynamic stability, the arrhythmia may resolve spontaneously after 24 to 48 hours in 26% of cases. For the other scenarios, the treatment of choice is elective electrical cardioversion or pharmacological cardioversion with amiodarone (5 mg/kg in 20 min); some other drugs that have been successfully used are digoxin and propafenone 53 . Neonates without arrhythmogenic substrate almost never have recurrences 1,10 .…”

Section: Treatmentmentioning

confidence: 99%

Neonatal supraventricular tachyarrhythmias, approach and treatment from pathophysiology

Hernández

Hoyos

Montana

et al. 2022

ACME

View full text Add to dashboard Cite

Supraventricular tachyarrhythmias of the neonatal period are alterations in the heart rhythm that produce an abnormal increase in the heart rate of the newborn, with possible deleterious effects on cardiac output, in a heart with a limited myocardial reserve and that carries a higher risk of fatal outcomes in special populations, such as patients with congenital or acquired heart disease. We present here a review of the literature, with the aim of achieving a timely recognition and management of neonatal supraventricular tachyarrhythmias, based on the diagnostic and therapeutic options available to date.

show abstract

Section: Treatmentmentioning

confidence: 99%

Neonatal supraventricular tachyarrhythmias, approach and treatment from pathophysiology

Hernández

Hoyos

Montana

et al. 2022

ACME

View full text Add to dashboard Cite

show abstract

“…En ausencia de enfermedad cardíaca estructural y estabilidad hemodinámica, la arritmia puede ceder espontáneamente después de 24 a 48 h en el 26% de los casos. Para los demás escenarios, el tratamiento de elección es la cardioversión eléctrica electiva o farmacológica con amiodarona (5 mg/kg en 20 min); algunos otros fármacos usados con éxito son la digoxina y la propafenona 53 . Los neonatos sin sustrato arritmogénico no presentan casi nunca recurrencias 1,10 .…”

Section: Tratamientounclassified

Taquiarritmias supraventriculares neonatales, aproximación y tratamiento desde la fisiopatología

Hernández

Hoyos

Montana

et al. 2021

ACM

View full text Add to dashboard Cite

Las taquiarritmias supraventriculares del período neonatal son alteraciones del ritmo cardíaco que producen un incremento anormal de la frecuencia cardíaca del recién nacido, con posibles efectos deletéreos en el gasto cardíaco, en un corazón con una reserva miocárdica limitada y que supone mayor riesgo de desenlaces letales en poblaciones especiales, como los pacientes con cardiopatías congénitas o adquiridas. Se presenta aquí una revisión de las publicaciones médicas con el objetivo de reconocer y tratar de modo oportuno las taquiarritmias supraventriculares neonatales, con base en las opciones diagnósticas y terapéuticas disponibles hasta el momento.

show abstract

An automated detection of atrial fibrillation from single‑lead ECG using HRV features and machine learning

Udawat¹,

Singh²

2022

Journal of Electrocardiology

View full text Add to dashboard Cite

Atrial fibrillation in preterm neonates: A case study

Cited by 4 publications

References 7 publications

Neonatal supraventricular tachyarrhythmias, approach and treatment from pathophysiology

Neonatal supraventricular tachyarrhythmias, approach and treatment from pathophysiology

Taquiarritmias supraventriculares neonatales, aproximación y tratamiento desde la fisiopatología

An automated detection of atrial fibrillation from single‑lead ECG using HRV features and machine learning

Contact Info

Product

Resources

About